Puma Biotechnology, Inc.
PBYI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001401667
In the last 90 days, Puma Biotechnology, Inc. insiders filed 0 open-market purchases and 5 sales; 160 institutions reported holding it in 13F filings for Q2 2026, worth $313.6M in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding Puma Biotechnology, Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Of which not filed for Q2 2025 | Q2 2025 | Change |
|---|---|---|---|---|
| Holders | 116 | 1 | 121 | +6 |
| Shares | 30.4M | 13.8K | 32.8M | +2.41M (+7.9%) |
| Value | $90.0M | $40.9K | $112.5M | +$22.6M (+25.1%) |
1 institution that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (22)
Institutions that held Puma Biotechnology, Inc. at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Janus Henderson Group PLC | 745,541 | $2.56M | 0.00% |
| Citadel Advisors LLC | 507,818 | $1.74M | 0.00% |
| Ritholtz Wealth Management | 196,985 | $675.7K | 0.01% |
| Evergreen Capital Management LLC | 96,000 | $329.3K | 0.01% |
| Hillsdale Investment Management Inc. | 84,800 | $290.9K | 0.01% |
| Panagora Asset Management Inc | 76,684 | $263.0K | 0.00% |
| State Board of Administration of Florida Retirement System | 71,727 | $246.0K | 0.00% |
| Kapitalo Investimentos Ltda | 70,269 | $241.0K | 0.05% |
| Jane Street Group, LLC | 39,448 | $135.3K | 0.00% |
| Empowered Funds, LLC | 38,292 | $131.3K | 0.00% |
| Kathmere Capital Management, LLC | 20,204 | $69.3K | 0.01% |
| Squarepoint Ops LLC | 17,794 | $61.0K | 0.00% |
| D'Orazio & Associates, Inc. | 15,027 | $51.5K | 0.01% |
| Ethic Inc. | 15,168 | $50.5K | 0.00% |
| Ieq Capital, LLC | 14,305 | $49.1K | 0.00% |
| Alliancebernstein L.P. | 13,800 | $47.3K | 0.00% |
| Cerity Partners LLC | 10,528 | $36.1K | 0.00% |
| Global Retirement Partners, LLC | 1,492 | $5.12K | 0.00% |
| Essential Partners LLC | 439 | $1.51K | 0.00% |
| Clearstead Advisors, LLC | 335 | $1.15K | 0.00% |
| Luminist Capital LLC | 250 | $898 | 0.00% |
| Allworth Financial LP | 1 | $4 | 0.00% |
Sold out (16)
Institutions that held Puma Biotechnology, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Gsa Capital Partners LLP | 99,394 | $294.0K |
| Integrated Quantitative Investments LLC | 59,727 | $176.8K |
| Man Group plc | 37,469 | $110.9K |
| Virtu Financial LLC | 31,477 | $93.0K |
| Bailard, Inc. | 24,702 | $73.1K |
| Dynamic Technology Lab Private Ltd | 22,030 | $66.0K |
| Corebridge Financial, Inc. | 20,618 | $61.0K |
| Oxford Asset Management LLP | 17,647 | $52.2K |
| Walleye Capital LLC | 13,055 | $38.6K |
| Graham Capital Management, L.P. | 12,752 | $37.7K |
| Quadrature Capital Ltd | 12,508 | $37.0K |
| Sherbrooke Park Advisers LLC | 12,224 | $36.2K |
| Patriot Financial Group Insurance Agency, LLC | 10,500 | $31.1K |
| Gateway Wealth Partners, LLC | 10,200 | $30.2K |
| Lazard Asset Management LLC | 2,100 | $6.00K |
| Coldstream Capital Management Inc | 304 | $900 |
Not filed for Q2 2025 yet (1)
Institutions that held Puma Biotechnology, Inc. at the end of Q1 2025 and haven't filed a 13F for Q2 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| CAPROCK Group, Inc. | 13,817 | $40.9K |